Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Resmed (RMD)
NYSE:RMD
Holding RMD?
Track your performance easily
RMD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$132.24 - $255.18
Previous Close$239
Volume1.13M
Average Volume (3M)975.01K
Market Cap
$35.12B
Enterprise Value$35.75B
Total Cash (Recent Filing)$238.36M
Total Debt (Recent Filing)$873.93M
Price to Earnings (P/E)34.5
Beta1.16
Next Earnings
Oct 24, 2024EPS Estimate
$2.05Last Dividend Ex-Date
Aug 15, 2024Dividend Yield0.82%
Share Statistics
EPS (TTM)6.92
Shares Outstanding146,932,119
10 Day Avg. Volume1,141,176
30 Day Avg. Volume975,015
Standard Deviation0.09
R-Squared0.15
Alpha0.00587
Financial Highlights & Ratios
Price to Book (P/B)7.22
Price to Sales (P/S)7.50
Price to Cash Flow (P/CF)20.00
P/FCF Ratio21.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.69
Enterprise Value/Gross Profit13.46
Enterprise Value/Ebitda25.54
Forecast
1Y Price Target
$233.50Price Target Upside-2.30% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering10
Resmed News
PremiumMarket News
SPY ETF Update, 9/20/2024 Bulls Say, Bears Say
Bulls Say
Financial PerformanceDespite unknowns, ResMed has a clear path to strong gross margin and operating margin expansion, driving mid-to-high teens EPS growth.
Growth OutlookThe company has a strong outlook into FY30 with expected growth in device, mask & accessory, and SaaS markets.
Market PositionResMed is best positioned to benefit from higher diagnosis rates with Respironics still absent from the US device market.
Bears Say
Market RisksLilly’s launch of an obstructive sleep apnea (OSA) indication for its GLP-1 medication tirzepatide poses significant patient funnel disruption/distortion risks.
Revenue EstimatesPHG's re-entrance and GLP-1's remain overhangs and downside risks to revenue estimates.
Stock ValuationShares appear 'priced to perfection' with a +30% move since Q2 lows, which might lead to profit-taking.
---
Ownership Overview
73.17% Insiders
1677.71% Mutual Funds
945.14% Other Institutional Investors
5071.10% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RMD FAQ
What was Resmed’s price range in the past 12 months?
Resmed lowest stock price was $132.24 and its highest was $255.18 in the past 12 months.
What is Resmed’s market cap?
Currently, no data Available
When is Resmed’s upcoming earnings report date?
Resmed’s upcoming earnings report date is Oct 24, 2024 which is in 20 days.
How were Resmed’s earnings last quarter?
Resmed released its earnings results on Aug 01, 2024. The company reported $2.08 earnings per share for the quarter, missing the consensus estimate of $2.083 by -$0.003.
Is Resmed overvalued?
According to Wall Street analysts Resmed’s price is currently Overvalued.
Does Resmed pay dividends?
Resmed pays a Quarterly dividend of $0.53 which represents an annual dividend yield of 0.82%. See more information on Resmed dividends here
What is Resmed’s EPS estimate?
Resmed’s EPS estimate is $2.05.
How many shares outstanding does Resmed have?
Resmed has 146,932,110 shares outstanding.
What happened to Resmed’s price movement after its last earnings report?
Resmed reported an EPS of $2.08 in its last earnings report, missing expectations of $2.083. Following the earnings report the stock price went up 4.233%.
Which hedge fund is a major shareholder of Resmed?
Among the largest hedge funds holding Resmed’s share is Greenvale Capital LLP. It holds Resmed’s shares valued at 139M.
---
Resmed Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$233.50 (-2.30% Downside)
$233.50 (-2.30% Downside)
Blogger Sentiment
Bullish
RMD Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 181.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $10.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 1.1%
Last 30 Days ▲ 1.9%
Last 30 Days ▲ 1.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
62.45%
12-Months-Change
Fundamentals
Return on Equity
22.70%
Trailing 12-Months
Asset Growth
1.79%
Trailing 12-Months
Company Description
Resmed
Founded in 1989, California-based ResMed, Inc. is a medical equipment company. The company is engaged in the development, manufacturing, distribution, and marketing of medical equipment and software solutions. The company operates through two segments: Sleep and Respiratory Care, and SaaS (Software as a Service).
---
RMD Company Deck
---
RMD Earnings Call
Q4 2024
0:00 / 0:00
---
RMD Revenue Breakdown
52.16% Devices
35.37% Masks and other
12.47% Software as a Service
---
RMD Stock 12 Month Forecast
Average Price Target
$233.50
▼(-2.30% Downside)
Technical Analysis
Best Analysts Covering RMD
1 Year
1 Year Success Rate
12/17 ratings generated profit
1 Year Average Return
+16.09%
assigned a buy rating 8 days ago
Copying Lyanne Harrison's trades and holding each position for 1 Year would result in 70.59% of your transactions generating a profit, with an average return of +16.09% per trade.
---